[结论。替诺福韦] - Suppr

[Conclusions. Tenofovir].

作者信息

Mallolas Josep

机构信息

Servicio de Enfermedades Infecciosas, Hospital Clínic, IDIBAPS, Facultat de Medicina, Universitat de Barcelona, Barcelona, España.

出版信息

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:62-4. doi: 10.1157/13126273.

DOI:10.1157/13126273

PMID:19195439

Abstract

摘要

相似文献

[Conclusions. Tenofovir].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:62-4. doi: 10.1157/13126273.

[Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:13-8. doi: 10.1157/13126267.

[3 years' data of tenofovir. Confirmed as a valuable building block].

MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:30-1.

[Clinical data I. Clinical experience with tenofovir in combination with nonnucleoside analogue transcriptase inhibitors].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:7-12. doi: 10.1157/13126266.

[Tenofovir: pharmacology and interactions].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:2-6. doi: 10.1157/13126265.

[Role of tenofovir in HIV and hepatitis C virus coinfection].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:31-7. doi: 10.1157/13126270.

[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].

Med Mal Infect. 2013 Mar;43(3):134-5. doi: 10.1016/j.medmal.2013.01.008. Epub 2013 Feb 20.

Prevalence and conditions of selection of the K65R mutation in the reverse transcriptase gene of HIV-1.

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):110-1. doi: 10.1097/00126334-200501010-00019.

[Are all analogue combinations equal?].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:38-44. doi: 10.1157/13126271.

Report from the 13th retrovirus conference. Renal tenofovir debate continues.

AIDS Clin Care. 2006 Apr;18(4):37-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Conclusions. Tenofovir].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:62-4. doi: 10.1157/13126273.

[Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:13-8. doi: 10.1157/13126267.

[3 years' data of tenofovir. Confirmed as a valuable building block].

MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:30-1.

[Clinical data I. Clinical experience with tenofovir in combination with nonnucleoside analogue transcriptase inhibitors].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:7-12. doi: 10.1157/13126266.

[Tenofovir: pharmacology and interactions].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:2-6. doi: 10.1157/13126265.

[Role of tenofovir in HIV and hepatitis C virus coinfection].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:31-7. doi: 10.1157/13126270.

[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].

Med Mal Infect. 2013 Mar;43(3):134-5. doi: 10.1016/j.medmal.2013.01.008. Epub 2013 Feb 20.

Prevalence and conditions of selection of the K65R mutation in the reverse transcriptase gene of HIV-1.

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):110-1. doi: 10.1097/00126334-200501010-00019.

[Are all analogue combinations equal?].

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:38-44. doi: 10.1157/13126271.

Report from the 13th retrovirus conference. Renal tenofovir debate continues.

AIDS Clin Care. 2006 Apr;18(4):37-8.

[Conclusions. Tenofovir].

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献